巴克莱2025年欧盟医疗技术与生命科学投资者之旅更新

•Gaurav Jain, European Consumer Staples and Head of European Small & Mid Cap•Preliminary AgendaMonday 15 September - Denmark- GN Store Nord - CEO meeting- Coloplast - CEO meeting- Ambu - CFO meeting- Demant - Management meetingTuesday & Wednesday 16/17 September - Switzerland- Straumann - CEO meeting and product demonstration- Alcon - Management meeting- Sonova - Management meeting- Bachem - CFO meeting- Roche Diagnostics - CEO meeting- Lonza - CFO meeting- Siegfried - CFO meeting and site visit*NEW*- Tecan - CEO/CFO meeting and product demonstrationThursday 18 September - Germany- Siemens Healthineers - Management meeting and site visit- Carl Zeiss Meditec- Management meeting- Fresenius SE - TBC- Gerresheimer - Management meeting*NEW*- Schott Pharma - CEO meeting*NEW*Friday 19 September - UK or GermanyUK- ConvaTec - CEO meeting- Spire Healthcare - CFO meeting- Oxford Nanopore - CFO meeting- Smith & Nephew -TBCGermany- Sartorius - Management meeting and site visitLogisticsGround transportation will be provided throughout. Suggested flight and hotelinformation to follow. Meet the analysts Hassan Al-Wakeel, CFA, is a Director and Head of theEuropean Medical Technology & Services equity researchteam at Barclays. He ranked #1 in his sector in the 2024Institutional Investor / Extel survey. Hassan joinedBarclays in 2017; he has over a decade of experience inequity research, previously working as a Global MedTechanalyst at GLG Partners and starting his career at DeutscheBank. He is a CFA Charterholder and graduated with a FirstClass Master's degree in Engineering Science from OxfordUniversity with a focus on Biomedical Engineering.View Analyst PageJon Unwin is a Vice President and research analystcovering the European Medical Technologies & Servicessector. He joined Barclays in 2025, having previouslyworked at Bernstein covering Medtech and before thatcovering Capital Goods and Oil Services. He is currentlystudying for an MSc in Health Economics, Policy andManagement from LSE and is a Chartered Accountant. Jonbegan his career at EY in Assurance and has a Bachelor’sdegree in Maths with Mathematical Physics from UCL.View Analyst PageMarco Pires-Cox is an Equity Research Analyst in theEuropean Medical Technology and Services team. Hegraduated from Imperial Business Schoolafterdoing anMSc in Investment and Wealth Management. Prior to this,he completed a BSc in Economics and Mathematics at theUniversity of Bath.View Analyst PageEmily Field is a Director and Head of the EuropeanPharmaceuticals team at Barclays. Ms. Field joinedBarclays and moved to London in December 2017, prior towhich she spent her career on the buy side in New YorkCity. Ms. Field worked at investment funds (including UBSO’Connor and Millennium Management) under variousstrategies, including Risk Arbitrage and Equity Long/Short.She has focused on fundamental analysis of thehealthcare/pharmaceutical sector for nearly 15 years. Shedouble majored in Economics and History at Yale Hassan Al-Wakeel, CFAJonathon Unwin+44 (0)20 7773 0354Barclays, UKRohit Rajan+91 (0) 22 6175 1698Barclays, UKUniversity and is also a CFA Charterholder. Ms. Field isoriginally from Chicago, Illinois.View Analyst PageCharles Pitman-King joined Barclays in 2022 as a VP in theEuropean pharmaceutical team to cover a selection ofmid-cap companies. His previous experience includescovering both mid-cap European and large-cap USpharmaceutical companies since 2018, as well as broadsector themes, such as the rapidly evolving COVID-19pandemic and sector ESG themes. Prior to this, he has alsohad experience covering the Aerospace and Defencesector, and working in financial modelling. He holds a firstclass Masters in Mathematics from Durham University andhas been a CFA charterholder since 2019.View Analyst PageGaurav Jain is a Director and Sector Head of three sectorteams: the Forestry, Paper & Packaging; EU Small & MidCap; and Global Tobacco teams, based in London. Gauravranked as #1 tobacco analyst in the 2024 Extel survey; thetobacco team also ranked #1 in the 2024 Extel survey. TheEU Small & Mid Cap team was runner-up in the 2024 Extelsurvey. Gaurav joined Barclays in 2017 from Martin Currie(anaffiliateof Legg Mason), where he spent two years asthe head of global consumer equity research. Between2007-15, Gaurav worked at Altavista Capital: a long-shortglobal fund as a generalist investor. Between 2003-07,Gaurav worked at Citigroup Asset Management andCitigroup Global Markets covering tech, media andtelecom stocks. Gaurav has an MBA from IIM Ahmedabad,and B.Tech in Electrical Engineering from IIT-Bombay.View Analyst PageEuropean Medical Technology & ServicesEuropean Pharmaceuticals & Life Sciences +44 (0)20 7773 3898Barclays, UKMarco Pires-Cox+44 (0)20 3134 3421Barclays, UK Emily Field, CFA+44 (0)20 7773 6263Barclays, UKGaurav Jain+44 (0)20 3555 2501Barclays, UKEuropean Small & Mid CapThis event is intended for Barclays institutional investor clients only. This event is strictly and sol